Desquamative extravasation reaction secondary to enfortumab vedotin
Saved in:
Main Authors: | Akshay N. Pulavarty, MD, MPH (Author), Shane Meehan, MD (Author), Jason Weed, MD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cutaneous reactions with enfortumab vedotin: A case series and review of the literature
by: Allison S. Dobry, MD, et al.
Published: (2021) -
A rare presentation of enfortumab vedotin-induced toxic epidermal necrolysis
by: Andrea Francis, BS, et al.
Published: (2021) -
Complete Pathologic Response With Pembrolizumab and Enfortumab Vedotin in Urothelial Carcinoma of the Upper Urinary Tract
by: Kok Hoe Chan MD, et al.
Published: (2024) -
Enfortumab vedotin-induced toxic epidermal necrolysis: A rare fatal adverse reaction
by: Aditi Bansal, et al.
Published: (2022) -
Characterization of cutaneous adverse events to enfortumab vedotin: A retrospective case-control study
by: Ahmad Shahin, BS, et al.
Published: (2023)